CSMD1, a regulator of complement activation and inflammation, has been proposed as a tumor suppressor gene in advanced oral, gastric, prostate and breast cancer and subsequent loss of CSMD1 functionality is associated to poor prognosis and enhanced proliferation, migration and invasion71–74. The gene discussed is CSMD1; the disease is breast carcinoma.